In the past week, MGRX stock has gone down by -17.95%, with a monthly decline of -69.70% and a quarterly plunge of -35.61%. The volatility ratio for the week is 14.38%, and the volatility levels for the last 30 days are 19.88% for Mangoceuticals Inc The simple moving average for the past 20 days is -49.46% for MGRX’s stock, with a -56.14% simple moving average for the past 200 days.
Is It Worth Investing in Mangoceuticals Inc (NASDAQ: MGRX) Right Now?
MGRX has 36-month beta value of 1.86.
The public float for MGRX is 2.87M, and currently, short sellers hold a 2.53% ratio of that float. The average trading volume of MGRX on April 08, 2025 was 158.64K shares.
MGRX) stock’s latest price update
Mangoceuticals Inc (NASDAQ: MGRX) has experienced a decline in its stock price by -13.04 compared to its previous closing price of 1.84. However, the company has seen a fall of -17.95% in its stock price over the last five trading days. globenewswire.com reported 2025-02-03 that Dallas, TX & Quebec, Canada, Feb. 03, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of men’s wellness products and services via a secure telemedicine platform, is pleased to announce that it has entered into an exclusive Master Distribution Agreement with Propre Energie, Inc., the developer of skincare brand Dermytol®, a clinically proven treatment designed to improve skin tone and reduce hyperpigmentation.
MGRX Trading at -56.79% from the 50-Day Moving Average
After a stumble in the market that brought MGRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.48% of loss for the given period.
Volatility was left at 19.88%, however, over the last 30 days, the volatility rate increased by 14.38%, as shares sank -67.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.49% lower at present.
During the last 5 trading sessions, MGRX fell by -17.95%, which changed the moving average for the period of 200-days by -64.47% in comparison to the 20-day moving average, which settled at $3.1655. In addition, Mangoceuticals Inc saw -33.88% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MGRX starting from Hamilton Alex P., who sale 108,426 shares at the price of $0.32 back on Jun 26 ’24. After this action, Hamilton Alex P. now owns 50,000 shares of Mangoceuticals Inc, valued at $34,696 using the latest closing price.
Hamilton Alex P., the Director of Mangoceuticals Inc, sale 16,574 shares at $0.31 during a trade that took place back on Jun 25 ’24, which means that Hamilton Alex P. is holding 158,426 shares at $5,138 based on the most recent closing price.
Stock Fundamentals for MGRX
Current profitability levels for the company are sitting at:
- -12.94 for the present operating margin
- 0.62 for the gross margin
The net margin for Mangoceuticals Inc stands at -14.14. The total capital return value is set at -0.57. Equity return is now at value -109.71, with -99.10 for asset returns.
Based on Mangoceuticals Inc (MGRX), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -22.63. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -17.17.
Currently, EBITDA for the company is -7.96 million with net debt to EBITDA at -0.02. When we switch over and look at the enterprise to sales, we see a ratio of 13.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.05.
Conclusion
To put it simply, Mangoceuticals Inc (MGRX) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
